SS

Sharmila Saha

Active Director Director DIN 09764055
DIN 09764055 First appointment Oct 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2022
Shareholding value •••• Premium profile

About Sharmila Saha

Data last updated:

Sharmila Saha is a Director at B2s Pharma Private Limited (since 2022). The company operates in Pharma. B2s Pharma Private Limited reported revenue of ₹1.21 Cr (FY 2022).

DIN 09764055
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2022
Oldest Company Age 10 yrs
Largest company B2s Pharma Private Limited · ₹1.21 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
B2s Pharma Private Limited U74900WB2016PTC209111
Director13 Oct 20222016₹1.21 Cr (FY 2022)Active

Board colleagues of Sharmila Saha

NameDINCompanyDesignation
Sudipta Das07358819B2s Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
B2s Pharma Private Limited
Premium access

Shareholding and investment profile for Sharmila Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharmila Saha

Sharmila Saha currently holds 1 directorship: B2s Pharma Private Limited (Director, since 13 Oct 2022, revenue ₹1.21 Cr (FY 2022)).

Sharmila Saha was first appointed on 13 Oct 2022 as Director at B2s Pharma Private Limited.

The current boards of Sharmila Saha's companies include Sudipta Das (B2s Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available